Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Indices fluctuate due to price swings in components and shifting sentiment. This short intro outlines the main causes of index volatility.
22,408 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
As Verizon nears its July 24 earnings, investors are eyeing a potential near-25% upside driven by steady cash flow, a...
A respected investment firm recently disclosed a new stake in Portland General Electric, adding a signal to watch for...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
Ondas (ONDS) reports its Q1 2026 results, revealing early signs of progress and persistent headwinds. This guide brea...
If you’re worried about crash artificial headlines in AI stocks, a simple, cost-efficient solution can help: diversif...
Intel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
As two iconic U.S. food brands, Krispy Kreme and McDonald’s attract very different types of investors. This article b...
As 2026 approaches, the investment narrative around quantum computing is shifting. This in-depth look explains why th...
The YieldMax MSFT Option Income Strategy ETF (MSFO) continues to lure income-seeking investors with weekly payouts, b...
SpaceX is speeding up its IPO timeline, shaking up the investing world. This guide breaks down 10 essential what-to-k...
An 11% one-day slide in the SPDR S&P Semiconductor ETF underscores how equal-weight funds magnify single-name moves, ...